Loading clinical trials...

HOPE Trial hCG or Progesterone Effect on Recurrent Pregnancy Loss | Clinical Trials | Clareo Health

WITHDRAWNPhase 2NCT05365464

HOPE Trial hCG or Progesterone Effect on Recurrent Pregnancy Loss

Up to half of all cases of recurrent pregnancy loss are unexplained (uRPL). Evidence points towards endometriosis and progesterone resistance as an underlying cause of uRPL. Previous non-RCT studies h...

Lead sponsor: Wake Forest University Health Sciences•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Start Free Trial

Trial snapshot

StatusWITHDRAWN

PhasePHASE2

Enrollment—

Start dateMay 2022

Last updatedMay 9, 2022

Condition

Recurrent Pregnancy Loss Without Current Pregnancy

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: May 9, 2022Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions